HAEM5:Adult T-cell leukaemia/lymphoma: Difference between revisions
Bailey.Glen (talk | contribs) Undo revision 21102 by Bailey.Glen (talk) Tag: Undo |
Richard.Glen (talk | contribs) m Section title fix |
||
| (One intermediate revision by one other user not shown) | |||
| Line 455: | Line 455: | ||
|Amplification | |Amplification | ||
| | | | ||
|}<center><span style="color:Maroon">'''End of V4 Section'''</span> | |}<center><span style="color:Maroon">'''End of V4 Section'''</span> </center> | ||
== Epigenomic Alterations == | == Epigenomic Alterations == | ||
| Line 490: | Line 490: | ||
|} | |} | ||
== Genetic Diagnostic Testing | == Genetic Diagnostic Testing Methods == | ||
Initial diagnosis of ATLL should include a comprehensive physical exam with skin evaluation and CT scans of the chest, abdomen and pelvis. The laboratory evaluation should include: a complete blood count (CBC), metabolic panel (serum electrolyte levels, calcium, creatinine and blood urea nitrogen) and serum LDH levels. Testing methods including PCR, Flow Cytometry, ELISA, serology, and immunohistochemistry in addition to morphologic studies may be employed to diagnose ATLL<ref name=":4">NCCN Clinical Practice Guidelines in Oncology, T-Cell Lymphomas, Version 1.2021. Available at NCCN.org.</ref>. | Initial diagnosis of ATLL should include a comprehensive physical exam with skin evaluation and CT scans of the chest, abdomen and pelvis. The laboratory evaluation should include: a complete blood count (CBC), metabolic panel (serum electrolyte levels, calcium, creatinine and blood urea nitrogen) and serum LDH levels. Testing methods including PCR, Flow Cytometry, ELISA, serology, and immunohistochemistry in addition to morphologic studies may be employed to diagnose ATLL<ref name=":4">NCCN Clinical Practice Guidelines in Oncology, T-Cell Lymphomas, Version 1.2021. Available at NCCN.org.</ref>. | ||